Sign In
Buy IRWD
$3.24
-0.0400 (-1.22%)
At Close: Jun 03, 2026
3 No-Brainer Stocks to Buy Right Now for Less Than $25
09:40am, Saturday, 04'th Feb 2023
All three healthcare stocks are showing solid long-term potential.
Ironwood Pharmaceuticals to Present at the 41st Annual J.P. Morgan Healthcare Conference
04:01pm, Wednesday, 04'th Jan 2023
BOSTON--( BUSINESS WIRE )--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, today announced that Tom McCourt, CEO, will present at the 41st Annual J.P. Morgan Healthcare
Ironwood's (IRWD) Q3 Earnings Beat, Linzess Volume Grows
01:34pm, Friday, 04'th Nov 2022
Ironwood (IRWD) beat earnings estimates in the third quarter. Sales, though missing estimates, rose year over year.
Ironwood Pharmaceuticals, Inc. (IRWD) Q3 2022 Earnings Call Transcript
12:07pm, Thursday, 03'rd Nov 2022
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD ) Q3 2022 Results Conference Call November 3, 2022 8:30 AM ET Company Participants Tom McCourt - Chief Executive Officer Mike Shetzline - Chief Medical Offi
Ironwood Pharmaceuticals (IRWD) Beats Q3 Earnings Estimates
09:47am, Thursday, 03'rd Nov 2022
Ironwood (IRWD) delivered earnings and revenue surprises of 3.70% and 2.58%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Ironwood Pharmaceuticals to Host Third Quarter 2022 Investor Update Call
04:01pm, Thursday, 20'th Oct 2022
BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD) today announced it will host its third quarter 2022 investor update conference call and webcast at 8:30 a.m.
2 Health Care Stocks That Fit Graham's Lost Formula
12:43pm, Thursday, 20'th Oct 2022
U.S. market indexes rose on Thursday morning as investors were encouraged by several key earnings reports and Treasury yields continued to climb.
Ironwood Pharmaceuticals: Rinse, Wash And Repeat
01:01pm, Wednesday, 05'th Oct 2022
Today, we are revisiting Ironwood Pharmaceuticals for the first time since April of 2021. The company continues to live off its Lizness franchise and is putting its cash flow to good use in paying dow
A Trio of Stocks With High Growth Potential
03:13pm, Sunday, 28'th Aug 2022
Looking for U.S.-listed equities that have the characteristics listed below represents a solid starting point when screening the market for potential value opportunities, in my opinion:
Ironwood Pharmaceuticals, Inc. (IRWD) CEO Tom McCourt on Q2 2022 Results - Earnings Call Transcript
03:17am, Saturday, 06'th Aug 2022
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD ) Q2 2022 Earnings Conference Call August 4, 2022 8:30 AM ET Company Representatives Tom McCourt - Chief Executive Officer Mike Shetzline - Chief Medical Of
Ironwood (IRWD) Q2 Earnings Miss, Keeps 2022 Sales Guidance
03:45pm, Friday, 05'th Aug 2022 Zacks Investment Research
Ironwood (IRWD) miss earnings and revenue estimates in the second quarter. Stock declines.
Ironwood (IRWD) Q2 Earnings Miss, Keeps 2022 Sales Guidance
12:47pm, Friday, 05'th Aug 2022
Ironwood (IRWD) miss earnings and revenue estimates in the second quarter. Stock declines.
Ironwood Pharmaceuticals (IRWD) Misses Q2 Earnings and Revenue Estimates
12:45pm, Thursday, 04'th Aug 2022 Zacks Investment Research
Ironwood (IRWD) delivered earnings and revenue surprises of -32.26% and 2.19%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Ironwood Pharmaceuticals to Host Second Quarter 2022 Investor Update Call
04:01pm, Thursday, 21'st Jul 2022
BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD) today announced it will host its second quarter 2022 investor update conference call and webcast at 8:30 a.m. Eastern Time on Thu
4 Graham-Style Stocks to Consider
12:50pm, Monday, 20'th Jun 2022
To increase your chances of discovering value opportunities, you may want to look for stocks whose Graham blended multipliers are below 22.5. Created by Benjamin Graham, the father of value investing,
